Get started
Author

Gérôme Jules-Clément

Observed names: G. Jules-Clément, Gerome Jules-Clement, Gerome Jules-Clément, Gérôme Jules-Clement, Gérôme Jules-Clément, Gérôme Jules Clément, Gérôme Jules-Clement, Gérôme Jules-clément, Jules-Clément, Gérôme
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris-Saclay, Institut Gustave Roussy, Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse, Fondation Gustave Roussy, École Nationale Supérieure des Mines de Paris, Institut Curie
ORCID: 0000-0002-6719-532X
Observed ORCID: 0000-0002-6719-532X
OpenAlex ID: A5010437670
Microbe-host interplay in atopic dermatitis and psoriasis
2019 · Nanna Fyhrquist, Gareth Muirhead, et al. · Nature Communications · 410
PDF
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
2024 · Roberto A. Leon-Ferre, Sarah Flora Jonas, et al. · JAMA · 240
Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial
2014 · Nicolas Servant, Julien Roméjon, et al. · Frontiers in Genetics · 90
PDF
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
2023 · Yoann Pradat, Julien Viot, et al. · Cancer Discovery · 57
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma
2023 · Julien Hadoux, Abir Al Ghuzlan, et al. · JCO Precision Oncology · 29
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
2022 · Nicolas Chapuis, Nusaibah Ibrahimi, et al. · EBioMedicine · 28
PDF
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders
2025 · David Fandrei, Jean Pegliasco, et al. · Clinical Cancer Research · 17
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development
2024 · Damien Vasseur, Ludovic Bigot, et al. · Molecular Cancer · 10
PDF
Abstract 3000: Molecular profiling of residual tumor cells after various chemotherapies shows distinct gene expression patterns in patient-derived breast cancer xenografts
2012 · David Gentien, Stéphane Depil, et al. · Cancer Research · 5
Single-cell transcriptome profiling of post-treatment and treatment-naïve colorectal cancer: Insights into putative mechanisms of chemoresistance
2025 · Grigory A. Puzanov, Clémence Astier, et al. · Cancer Letters · 4
PDF
Assessing actionability and incidental findings of germline variants in two precision oncology trials
2024 · Maria Baz Ibrahim, Yahia Adnani, et al. · European Journal of Cancer · 4
PDF
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival
2026 · Y. Wang, D. Drubay, et al. · Annals of Oncology · 1
Data from Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders
2025 · David Fandrei, Jean Pegliasco, et al. · 1
Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
2025 · Dimitrios Papakonstantinou, Haiding Wang, et al. · Cancer Treatment and Research Communications · 1
Single-cell trajectories in metastatic urothelial carcinoma reveal tumor–immune reprogramming and macrophage-driven resistance to PD-(L)1 blockade
2026 · Ronan Flippot, Amélie Roehrig, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Supplementary Figures S1-S24 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
2025 · Yoann Pradat, Julien Viot, et al.
Supplementary Tables S1-S11 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
2025 · Yoann Pradat, Julien Viot, et al.
Prospective monitoring of 591 cancer patients with clonal hematopoiesis detected in daily practice
2025 · Mégane Tanguay, David Fandrei, et al. · Blood
Supplementary Data 1 from Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders
2025 · David Fandrei, Jean Pegliasco, et al.
Supplementary Data 1 from Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders
2025 · David Fandrei, Jean Pegliasco, et al.
Abstract 1276: UNLOCK, a preclinical platform of PDX models resistant to innovative therapies
2025 · Ludovic Bigot, Nobre Nobre, et al. · Cancer Research
Abstract 738: Single-cell trajectories of metastatic urothelial cancer and individual patterns of resistance to immune checkpoint inhibitors
2025 · Ronan Flippot, Amélie Roehrig, et al. · Cancer Research
Supplementary Figures S1-S24 from Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
2024 · Yoann Pradat, Julien Viot, et al.
Supplementary Tables S1-S11 from Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
2024 · Yoann Pradat, Julien Viot, et al.
Data from Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
2024 · Yoann Pradat, Julien Viot, et al.
Works count: 43
Citation count: 897
H-index: 8
I10-index: 8
Year
Topic
Type